Purchases and Sales Made in Q3 2021 in Anebulo Pharmaceuticals, Inc. (ANEB)
This table provides information about the institutional ownership of Anebulo Pharmaceuticals, Inc. (ANEB) during Q3 2021. The information is specifically focused on institutions that hold shares of Anebulo Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 15, 2021
Q3 2021
|
Ubs Group Ag
|
BUY
|
- |
614+ 262.39% |
$4.02K - $4.77K
|
848
$1.24K
|
|
|
Nov 09, 2021
Q3 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-119- 75.32% |
$779 - $925
|
39
$56.9
|
|
|
Nov 09, 2021
Q3 2021
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-160- 2.06% |
$1.05K - $1.24K
|
7.61K
$11.1K
|
|
|
Nov 15, 2021
Q3 2021
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-2.5K- 1.43% |
$16.4K - $19.4K
|
172K
$252K
|
|
|
Nov 15, 2021
Q3 2021
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-2.5K- 12.61% |
$16.4K - $19.4K
|
17.3K
$25.3K
|
|
|
Nov 15, 2021
Q3 2021
|
Mangrove Partners
New York, NY |
SELL
|
- |
-12K- 2.79% |
$78.3K - $92.9K
|
417K
$608K
|